Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
17,410,719
-
Number of holders
-
9
-
Total 13F shares, excl. options
-
367,377
-
Shares change
-
+79,880
-
Total reported value, excl. options
-
$817,414
-
Value change
-
+$224,883
-
Number of buys
-
6
-
Number of sells
-
4
-
Price
-
$2.22
Institutional Holders of ABVC BIOPHARMA, INC. - Common Stock, par value $0.001 per share (ABVC) as of Q2 2025
As of 30 Jun 2025 ABVC BIOPHARMA, INC. - Common Stock, par value $0.001 per share (ABVC) had 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 367,377 shares of stock of the company.
Largest 9 holders included VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, XTX Topco Ltd, RENAISSANCE TECHNOLOGIES LLC, NORTHERN TRUST CORP, STATE STREET CORP, SBI Securities Co., Ltd., Tower Research Capital LLC (TRC), and BANK OF AMERICA CORP /DE/.
This table shows 9 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.